Dia Beta Labs
UK - BelfastBiotechnology
Focus: Dia Beta Labs is a UK-based biotechnology company focused on diabetes and obesity treatments within the metabolic disease space. Company scale and stage details are not publicly available.
Profile data last refreshed 10h ago · AI intelligence enriched 2mo ago
Open Jobs
3+3 this month
Stable — net +3 jobs in 30d
3 added, 0 removed. Backfill posture.
Should You Work at Dia Beta Labs?
AI assessmentHigh-risk early-stage opportunity with unclear clinical progress and hiring freeze; suitable only for risk-tolerant candidates betting on diabetes/obesity focus.
Why Work Here
- Focused therapeutic area (diabetes & obesity) in high-demand metabolic disease space with significant market opportunity
- UK-based location offers potential access to European regulatory pathways and research talent
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Dia Beta Labs
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.